Researchers at the University of Maryland, College Park and Baltimore campuses are working to shed new light on how, one day, immune tissues could be designed and implanted to create next-generation vaccines or immunotherapies for a range of diseases, or serve as cutting-edge tools for the early diagnosis of cancers or other illnesses.
{iframe}https://bioe.umd.edu/news/news_story.php?id=11362{/iframe}